Inventor
MCEACHERN ERNEST J
CA41 patents
⚠️ This page may combine multiple inventors who share the name “MCEACHERN ERNEST J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ANORMED INC
11 patentsUS6750348B1Jun 15, 2004
Chemokine receptor binding heterocyclic compounds
ANORMED INC61 citations96
US6864265B2Mar 8, 2005
Chemokine receptor binding heterocyclic compounds
ANORMED INC42 citations95
US6835731B2Dec 28, 2004
Chemokine receptor binding heterocyclic compounds
ANORMED INC53 citations95
US7354934B2Apr 8, 2008
Chemokine receptor binding heterocyclic compounds with enhanced efficacy
ANORMED INC34 citations92
US7354932B2Apr 8, 2008
Chemokine receptor binding heterocyclic compounds with enhanced efficacy
ANORMED INC27 citations92
US7091217B2Aug 15, 2006
Chemokine receptor binding heterocyclic compounds
ANORMED INC31 citations92
US6825351B2Nov 30, 2004
Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
ANORMED INC34 citations92
US6734191B2May 11, 2004
Chemokine receptor binding heterocyclic compounds
ANORMED INC35 citations92
US7452994B2Nov 18, 2008
Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
ANORMED INC18 citations91
US7135570B2Nov 14, 2006
Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
ANORMED INC18 citations91
US7183273B2Feb 27, 2007
Chemokine receptor binding heterocyclic compounds
ANORMED INC2 citations62
GENZYME CORP
8 patentsUS7291631B2Nov 6, 2007
CXCR4 chemokine receptor binding compounds
GENZYME CORP50 citations95
US7863293B2Jan 4, 2011
CXCR4 chemokine receptor binding compounds
GENZYME CORP24 citations92
US7550484B2Jun 23, 2009
Chemokine receptor binding heterocyclic compounds with enhanced efficacy
GENZYME CORP19 citations83
US10322111B2Jun 18, 2019
Chemokine receptor binding heterocyclic compounds with enhanced efficacy
GENZYME CORP1 citations71
US7396840B2Jul 8, 2008
Chemokine receptor binding heterocyclic compounds
GENZYME CORP1 citations62
US7629337B2Dec 8, 2009
Chemokine receptor binding heterocyclic compounds
GENZYME CORP1 citations52
US7807694B2Oct 5, 2010
Chemokine receptor binding heterocyclic compounds
GENZYME CORP0 citations51
US7790747B2Sep 7, 2010
Chemokine receptor binding compounds
GENZYME CORP0 citations40
ALECTOS THERAPEUTICS INC
8 patentsUS9796680B2Oct 24, 2017
Glucocerebrosidase modulators and uses thereof
ALECTOS THERAPEUTICS INC2 citations71
US9522883B2Dec 20, 2016
Glycosidase inhibitors and uses thereof
ALECTOS THERAPEUTICS INC2 citations61
US10081601B2Sep 25, 2018
Glucocerebrosidase modulators and uses thereof
ALECTOS THERAPEUTICS INC0 citations51
US9670195B2Jun 6, 2017
Glycosidase inhibitors and uses thereof
ALECTOS THERAPEUTICS INC0 citations51
US12528773B2Jan 20, 2026
Non-lysosomal glucosylceramidase inhibitors and uses thereof
ALECTOS THERAPEUTICS INC0 citations50
US9815861B2Nov 14, 2017
Selective glycosidase inhibitors and uses thereof
ALECTOS THERAPEUTICS INC0 citations50
US9809537B2Nov 7, 2017
Glycosidase inhibitors and uses thereof
ALECTOS THERAPEUTICS INC0 citations40
US9695197B2Jul 4, 2017
Glycosidase inhibitors and uses thereof
ALECTOS THERAPEUTICS INC0 citations40
LI TONG-SHUANG
3 patentsMERCK SHARP & DOHME
3 patentsUS9938299B2Apr 10, 2018
Glycosidase inhibitors and uses thereof
MERCK SHARP & DOHME5 citations72
US10913733B2Feb 9, 2021
Substituted piperidines thiazolyl acetamides as glycosidase inhibitors and uses thereof
MERCK SHARP & DOHME0 citations52
US9611275B2Apr 4, 2017
Permeable glycosidase inhibitors and uses thereof
MERCK SHARP & DOHME0 citations40